IKZF1 and acute lymphoblastic leukemia: Whereas the isolated impact of IKZF1 deletions on Ph+ ALL remains debatable, the association of this alteration with other copy-number alterations (CNA)—known as the “IKZF1-plus” subgroup—consistently demonstrates poor survival in this disease [32,33].